You are here



NorDiag ASA today announced that its wholly owned US subsidiary NorDiag Inc., Atlanta, GA, USA, entered into a distribution agreement with AutoGen Inc., Holliston, MA, USA, for distribution of NorDiag products to the Life Science market in North America.

The agreement includes distribution of instruments and chemistry specifically designed for the life sciences market. The agreement has a time frame of 5 years with an option for a further 2 years. The parties have not released financial terms of the agreement, but NorDiag expects that AutoGen will be able to make a significant sales impact in 2012 and beyond. 

Bob Sullivan, President of AutoGen comments: "We are pleased to be able to offer NorDiag's products to our customer base. The addition of these systems to our line-up fits our strategy of providing our clients with the highest quality products backed by the best support in the industry."

Mårten Wigstøl, CEO of NorDiag said: "We are pleased with the addition of AutoGen as a distributor of our products to the life science market. Our strategy is to establish ourselves in the region through strong partners and this agreement confirms that our products are attractive for end users in the Life Science market as well as in the Diagnostics market.

For further information, please contact:
CEO Mårten Wigstøl,  Phone: +47 911 65775
CFO Tone Kvåle, Phone: +47 915 19576
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden and in Atlanta (GA), USA. The group has today 31.6 man-labour years. NorDiag is listed on the Oslo Stock Exchange with ticker NORD.
For further information -

About AutoGen: 
AutoGen is a privately held, value-added supplier of nucleic acid extraction equipment and sample preparation solutions to the life science community. Our mission is to provide products of premier quality and value, backed by scientific and technical support that exceeds the requirements of our clients.

Read the notice in Norwegian here.